Overview
Prominent glabella-microcephaly-hypogenitalism syndrome (also known as Juberg-Hayward syndrome or orocraniodigital syndrome) is an extremely rare congenital malformation syndrome characterized by a distinctive combination of craniofacial, genital, and digital anomalies. The condition was first described by Juberg and Hayward in 1969. Key clinical features include microcephaly (abnormally small head), a prominent glabella (the area between the eyebrows), cleft lip and/or cleft palate, hypogenitalism (underdevelopment of the genitalia), and hand anomalies including hypoplastic or absent thumbs and short fingers. Additional features may include growth retardation, intellectual disability of variable severity, and renal anomalies. The craniofacial features are typically apparent at birth and include a flat nasal bridge with the characteristically prominent glabella giving a distinctive facial appearance. The digital anomalies primarily affect the thumbs, which may be small, abnormally placed, or absent. Males may present with micropenis, cryptorchidism, or hypospadias, while females may show hypoplastic labia. There is no specific curative treatment for this syndrome. Management is supportive and symptomatic, involving surgical correction of cleft lip/palate, reconstructive hand surgery when indicated, hormonal evaluation and management for hypogonadism, and developmental support services for children with intellectual disability. A multidisciplinary approach involving geneticists, plastic surgeons, orthopedic specialists, endocrinologists, and developmental pediatricians is recommended.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Prominent glabella-microcephaly-hypogenitalism syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Prominent glabella-microcephaly-hypogenitalism syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Prominent glabella-microcephaly-hypogenitalism syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Prominent glabella-microcephaly-hypogenitalism syndrome.
Community
No community posts yet. Be the first to share your experience with Prominent glabella-microcephaly-hypogenitalism syndrome.
Start the conversation →Latest news about Prominent glabella-microcephaly-hypogenitalism syndrome
No recent news articles for Prominent glabella-microcephaly-hypogenitalism syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Prominent glabella-microcephaly-hypogenitalism syndrome
What is Prominent glabella-microcephaly-hypogenitalism syndrome?
Prominent glabella-microcephaly-hypogenitalism syndrome (also known as Juberg-Hayward syndrome or orocraniodigital syndrome) is an extremely rare congenital malformation syndrome characterized by a distinctive combination of craniofacial, genital, and digital anomalies. The condition was first described by Juberg and Hayward in 1969. Key clinical features include microcephaly (abnormally small head), a prominent glabella (the area between the eyebrows), cleft lip and/or cleft palate, hypogenitalism (underdevelopment of the genitalia), and hand anomalies including hypoplastic or absent thumbs a
How is Prominent glabella-microcephaly-hypogenitalism syndrome inherited?
Prominent glabella-microcephaly-hypogenitalism syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Prominent glabella-microcephaly-hypogenitalism syndrome typically begin?
Typical onset of Prominent glabella-microcephaly-hypogenitalism syndrome is neonatal. Age of onset can vary across affected individuals.